Neeta Somaiah

Trials

Studies that name Neeta Somaiah as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:00 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06474676 · T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

  M.D. Anderson Cancer Center · recruiting · Metastatic Soft-tissue Sarcoma · principal investigator
• Ph1
  NCT06308419 · A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

  M.D. Anderson Cancer Center · active not recruiting · Leiomyosarcoma, Soft-tissue Sarcomas · principal investigator
• Ph2
  NCT06087263 · Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.

  M.D. Anderson Cancer Center · active not recruiting · Gastrointestinal Stromal Tumors · principal investigator
• Ph2
  NCT05017103 · Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study

  M.D. Anderson Cancer Center · terminated · Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma · principal investigator
• Ph2
  NCT04668300 · Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

  M.D. Anderson Cancer Center · active not recruiting · Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma · principal investigator
• Ph1
  NCT03450122 · Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

  M.D. Anderson Cancer Center · completed · HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma · principal investigator
• Ph2
  NCT02815995 · Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes

  M.D. Anderson Cancer Center · completed · Advanced and/or Metastatic Sarcoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Experimental Medicine Program
  P30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026
  Named on NCT04668300